BiondVax Pharmaceuticals Ltd.
BVXVW
BVXVW was delisted on the 13th of May, 2020.
3 hedge funds and large institutions have $68K invested in BiondVax Pharmaceuticals Ltd. in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
113% more capital invested
Capital invested by funds: $32K → $68K (+$36K)
0% more funds holding
Funds holding: 3 → 3 (0)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$541 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
1
CVI Holdings
Wilmington,
Delaware
| $52K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $15K | -$541 | -500 | -2% |
|
3
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
BVXVW Hedge Fund Activity: Q2 2019 in Review
3 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in BiondVax Pharmaceuticals Ltd. (BVXVW) for Q2 2019, worth a combined $68K — up 113% from $32K a quarter earlier.
Fund positioning in BVXVW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $541.
- 3 institutional investors held BiondVax Pharmaceuticals Ltd. (BVXVW) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $68K of BiondVax Pharmaceuticals Ltd. stock for Q2 2019, up 113% quarter-over-quarter.
- 0 funds opened new BiondVax Pharmaceuticals Ltd. positions in Q2 2019 and 0 closed out.
- The largest BiondVax Pharmaceuticals Ltd. seller in Q2 2019 was Susquehanna International Group, an estimated $541 sold.
Based on aggregated 13F filings for Q2 2019.